These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Use of health-related quality of life information in managed care formulary decision-making. Wu WK; Sause RB; Zacker C Res Social Adm Pharm; 2005 Dec; 1(4):579-98. PubMed ID: 17138497 [TBL] [Abstract][Full Text] [Related]
23. Reframing the pharmaceutical manufacturer/health plan relationship in managed care. Studin I Manag Care; 2002 Feb; 11(2):46, 49-54. PubMed ID: 11904913 [TBL] [Abstract][Full Text] [Related]
24. The Academy of Managed Care Pharmacy's format for formulary submission. Penna P Manag Care Interface; 2001 Jun; 14(6):61-2. PubMed ID: 11432152 [No Abstract] [Full Text] [Related]
25. Targeting formulary pull-through strategies: the role of pharmaceutical manufacturers. Navarro RP Manag Care Interface; 1999 May; 12(5):84-6. PubMed ID: 10537482 [No Abstract] [Full Text] [Related]
26. Managing prescription drug costs. Sica JM Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515 [TBL] [Abstract][Full Text] [Related]
28. Pain management. Health plans need to take control. Sipkoff M Manag Care; 2003 Oct; 12(10):20-6. PubMed ID: 14598538 [No Abstract] [Full Text] [Related]
29. Congestive heart failure disease management in Medicare-managed care. Mehrotra A; McNeil BJ; Landon BE Am Heart J; 2007 Dec; 154(6):1153-9. PubMed ID: 18035089 [TBL] [Abstract][Full Text] [Related]
30. Formulary status of antihypertensive drug classes. Manag Care; 2003 Aug; 12(8 Suppl Hypertension):66-8. PubMed ID: 12971595 [No Abstract] [Full Text] [Related]
31. Improving compliance through health care system and pharmaceutical company partnerships. Kozma CM Manag Care Interface; 2003 Mar; 16(3):29-30. PubMed ID: 12715409 [No Abstract] [Full Text] [Related]
32. Formulary submission process catches on ... slowly. Cross M Manag Care; 2002 Nov; 11(11):32-6. PubMed ID: 12491856 [No Abstract] [Full Text] [Related]
33. Where do the new agents fit in hypertension management? Kopes-Kerr CP Am Fam Physician; 1996 Jun; 53(8):2427-8. PubMed ID: 8644557 [No Abstract] [Full Text] [Related]
34. Managed care's atypical response. New antipsychotics show promise, but are they getting into enough hands? Waldron T Behav Healthc Tomorrow; 1999 Apr; 8(2):28-31. PubMed ID: 10351297 [No Abstract] [Full Text] [Related]
35. Health plans begin to address chronic care management. Sipkoff M Manag Care; 2003 Dec; 12(12):24-5, 29-31. PubMed ID: 14723099 [No Abstract] [Full Text] [Related]
36. Formulary decision-making considerations: COX-2 inhibitors. Shaya FT; Wong W; Shin JY; Martin L; Samant N Manag Care Interface; 2004 Nov; 17(11):29-36, 41. PubMed ID: 15573802 [TBL] [Abstract][Full Text] [Related]
37. Disease management practices of health plans. Welch WP; Bergsten C; Cutler C; Bocchino C; Smith RI Am J Manag Care; 2002 Apr; 8(4):353-61. PubMed ID: 11950130 [TBL] [Abstract][Full Text] [Related]
38. The Pharmaceutical Management Panel - highlights of the pharmacy business. Kirshenbaum D Dis Manag; 2003; 6(Suppl 1):S15-7. PubMed ID: 14751024 [No Abstract] [Full Text] [Related]
39. Disease management and business alliances. Russell BA; Patneau KM; Tremonti L Pharm Pract Manag Q; 1998 Apr; 18(1):81-9. PubMed ID: 10177545 [No Abstract] [Full Text] [Related]
40. Treatment of hypertension in a managed care setting. DiTusa L; Luzier AB; Jarosz DE; Snyder BD; Izzo JL Am J Manag Care; 2001 May; 7(5):520-4. PubMed ID: 11388131 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]